-
- Kiyonori Kanemitsu and Yoshihiro Kakeji.
- Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine.
- Nippon Rinsho. 2014 Jan 1;72(1):114-9.
AbstractThere are several molecular target therapeutic drugs for colorectal cancer which are used in daily medical practice in Japan. One is bevacizumab which is anti-VEGF antibody, and another is cetuximab and panitumumab which are anti-EGFR antibodies. However, there is not a clear conclusion which drugs should be used in each therapeutic line, and many studies are in progress. The results of the direct competitive examination of anti-VEGF antibody and anti-EGFR antibodies have been reported recently. These drugs are under consideration to differentiate the use not only from the characteristic of the drugs, but also from the pathological condition of the tumor. In this report, we will show the latest findings and the use of each drugs.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..